PATH | VRL
Menu

WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of epidemiological settings in the context of other malaria prevention interventions; and information on potential rebound in which disease increases subsequent to the intervention. In addition, a malaria vaccine would require attention to additional factors, such as costs and cost-effectiveness, supply and demand, impact of use on other interventions, and distribution issues. Although policy issues may be more complex for future vaccines, the lead-time between the date of product regulatory approval and a recommendation for its use in developing countries is decreasing. This study presents approaches to define in advance core data needs to support evidence-based decisions, to further decrease this lead-time, accelerating the availability of a malaria vaccine. Specific policy areas for which information should be collected are defined, including studying its use within the context of other malaria interventions.

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Published: 2010

» Download file (English)

723 KB PDF (Located at www.malariajournal.com)

Resource types: Peer-reviewed journal

Diseases/vaccines: Haemophilus influenzae type b (Hib), Malaria, Pneumococcus, Rotavirus

Topics: Disease/vaccine specific information

Regions: Global